Initial human evaluation of argon laser-assisted vascular anastomoses. 1989

R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
Division of Vascular Surgery, Harbor-UCLA Medical Center, Torrance 90509.

Forearm Brescia-Cimino arteriovenous fistulas were chosen for the initial clinical evaluation of argon laser-assisted anastomosis of human vessels. Ten patients with chronic renal failure had side-to-side radial artery/cephalic vein fistulas fused by laser. Incisions 1.2 to 1.5 cm in length were made in adjacent segments of artery and vein and were aligned for application of laser energy by four 6-0 polypropylene sutures. The sutures divided each fistula into four segments that were 5.0 to 6.5 mm long. Each segment was sealed satisfactorily in 75 to 100 seconds by use of 0.5 W, 1130 to 1520 joule/cm2 argon laser energy fluence. Seven (17.5%) of 40 bonds required an additional 7-0 biodegradable suture to close small gaps that did not fuse adequately. Serial prospective follow-up studies of the patients by physical examination and duplex scanning for periods of 12 to 20 months (15.4 +/- 2.8, n = 7) postoperatively have shown uniformly patent, compliant anastomoses with no evidence of hematomas, false aneurysms, or luminal narrowing. Histologic examination of two patent fistulas that were excised during revision procedures at 4 and 5 months postoperatively showed healing of the entire circumference of the anastomosis similar to that noted in extensive preclinical canine studies. We conclude from these preliminary results that argon laser vascular tissue fusion is possible in humans when reliable primary sealing of vascular anastomoses is achieved, and that healing occurs without aneurysmal dilatation during follow-up of up to 20 months.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D011126 Polypropylenes Propylene or propene polymers. Thermoplastics that can be extruded into fibers, films or solid forms. They are used as a copolymer in plastics, especially polyethylene. The fibers are used for fabrics, filters and surgical sutures. Propene Polymers,Propylene Polymers,Hostalen,Marlex,Marlex Polypropylene,Polypro,Polypropylene,Prolene,Polymers, Propene,Polymers, Propylene,Polypropylene, Marlex
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005542 Forearm Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST. Antebrachium,Antebrachiums,Forearms
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001166 Arteriovenous Shunt, Surgical Surgical shunt allowing direct passage of blood from an artery to a vein. (From Dorland, 28th ed) Shunt, Surgical Arteriovenous,Surgical Arteriovenous Shunt,Arteriovenous Shunts, Surgical,Shunts, Surgical Arteriovenous,Surgical Arteriovenous Shunts

Related Publications

R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
January 1995, Microsurgery,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
January 1994, Lasers in surgery and medicine,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
January 1991, Lasers in surgery and medicine,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
August 1976, American journal of ophthalmology,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
September 1987, Archives of otolaryngology--head & neck surgery,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
October 1988, Annals of the Academy of Medicine, Singapore,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
August 1990, Archives of surgery (Chicago, Ill. : 1960),
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
May 1992, Urology,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
March 2000, Seminars in vascular surgery,
R A White, and G H White, and R M Fujitani, and J W Vlasak, and C E Donayre, and G E Kopchok, and S K Peng
January 1986, Arquivos brasileiros de cardiologia,
Copied contents to your clipboard!